Regulation of endogenous antioxidant systems in diabetic retinopathy
糖尿病视网膜病变内源性抗氧化系统的调节
基本信息
- 批准号:8973553
- 负责人:
- 金额:$ 37.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-12-01 至 2017-11-30
- 项目状态:已结题
- 来源:
- 关键词:AblationAcetylationAntioxidantsBiologicalBiological AvailabilityBlindnessChronicComplexDataDeacetylationDevelopmentDiabetes MellitusDiabetic RetinopathyDown-RegulationEndothelial CellsEventFunctional disorderGenesGlucoseGoalsHDAC6 geneHealthHomeostasisHumanHyperglycemiaImpairmentIn VitroInflammationInflammatoryInflammatory ResponseLeadMediatingModelingModificationMolecularNitratesOxidation-ReductionOxidative StressOxidative Stress InductionPathogenesisPatientsPericytesPhosphorylationPlayPost-Translational Protein ProcessingProcessProteinsRegulationRetinaRetinalRoleSerineSmall Interfering RNAStreptozocinSystemTXN geneTXNIP geneTestingTimeantioxidant therapydesigndiabeticdiabetic ratgain of functionin vivomutantnitrationoverexpressionpreventprotein kinase C-deltaresearch studythioredoxin reductase 1
项目摘要
DESCRIPTION (provided by applicant): We aim at investigating the molecular mechanisms of hyperglycemia-induced dysfunction of the endogenous antioxidant system of the thioredoxins (TrxS) in the diabetic retina. Our overall goal is to identify ways to rescue the activity of this critical regulator of cellular redox homeostasis in diabetes mellitus, thereby, preventing hyperglycemia-induced oxidative stress (OxS) and chronic inflammatory processes. To date, hyperglycemia-induced loss of TrxS function has been attributed only to increased expression of the thioredoxin interacting protein (TXNIP). However, in streptozotocin-induced diabetic rats (STZ-rats) and human diabetic retinas, we have discovered that hyperglycemia promotes serine phosphorylation of TXNIP (TXNIP- SerP), nitration/inactivation of the thioredoxin reductase 1(TrxR1-NY) and deacetylation of thioredoxin 1(Trx1). These modifications are associated with decreased bioavailability of the reduced (active) form of Trx1, the operating unit of the system, and with TXNIP gain of function. We have also determined that TXNIP and Trx1 post-translational modifications, involve the activity of protein kinase C delta (PKC?) and histone deacetylase 6 (HDAC6), respectively, implicating for the first time HDAC6 in the pathogenesis of DR and disclosing a new function of PKC??in the diabetic retina. We have designed experiments aimed at validating our hypothesis that: in the diabetic retina, impaired function of TrxS results from TXNIP serine phosphorylation, TrxR1 nitration/ inactivation and Trx1 deacetylation. These modifications of the TrxS constituents will lead to impaired antioxidant ability, induction of inflammatory processes and progression to DR. We have designed experiments to be conducted in vitro on isolated retinal pericytes (RPC) and endothelial cells (REC) exposed to elevated glucose levels (HG) and osmotic controls. In vivo experiments will be conducted by using streptozotocin-induced diabetic rats (STZ-rats, a model of Type1 diabetes). Aim1. Test the hypothesis that PKCd-dependent TXNIP-SerP contributes to retinal OxS, inflammation and progression to DR. Aim2. Test the hypothesis that TrxR1-NY contributes to retinal OxS and progression to DR. Aim3. Test the hypothesis that HDAC6-mediated de-acetylation of Trx1 contributes to retinal OxS, inflammation and progression to DR.
描述(申请人提供):我们的目的是研究高血糖诱导糖尿病视网膜中硫氧还蛋白(TrxS)内源性抗氧化系统功能障碍的分子机制。我们的总体目标是找到方法来挽救糖尿病细胞氧化还原稳态的关键调节剂的活性,从而预防高血糖诱导的氧化应激(OxS)和慢性炎症过程。迄今为止,高血糖引起的 TrxS 功能丧失仅归因于硫氧还蛋白相互作用蛋白 (TXNIP) 表达的增加。然而,在链脲佐菌素诱导的糖尿病大鼠(STZ-rats)和人类糖尿病视网膜中,我们发现高血糖促进TXNIP(TXNIP-SerP)的丝氨酸磷酸化、硫氧还蛋白还原酶1(TrxR1-NY)的硝化/失活以及硫氧还蛋白1(Trx1)的脱乙酰化。这些修饰与系统操作单元 Trx1(活性)还原形式的生物利用度降低以及 TXNIP 功能增益相关。我们还确定TXNIP和Trx1翻译后修饰分别涉及蛋白激酶Cδ(PKC?)和组蛋白脱乙酰酶6(HDAC6)的活性,首次暗示HDAC6与DR的发病机制有关,并揭示了PKC在糖尿病视网膜中的新功能。我们设计的实验旨在验证我们的假设:在糖尿病视网膜中,TrxS 功能受损是由于 TXNIP 丝氨酸磷酸化、TrxR1 硝化/失活和 Trx1 脱乙酰化造成的。 TrxS 成分的这些修饰将导致抗氧化能力受损、诱导炎症过程并进展为 DR。我们设计了在体外对暴露于升高的葡萄糖水平(HG)和渗透压控制的分离的视网膜周细胞(RPC)和内皮细胞(REC)进行的实验。将使用链脲佐菌素诱导的糖尿病大鼠(STZ-大鼠,1型糖尿病模型)进行体内实验。目标1。检验以下假设:PKCd 依赖性 TXNIP-SerP 有助于视网膜 OxS、炎症和进展为 DR。目标2。检验 TrxR1-NY 有助于视网膜 OxS 和进展为 DR 的假设。目标3。检验 HDAC6 介导的 Trx1 去乙酰化有助于视网膜 OxS、炎症和进展为 DR 的假设。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MANUELA BARTOLI其他文献
MANUELA BARTOLI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MANUELA BARTOLI', 18)}}的其他基金
Regulation of endogenous antioxidant systems in diabetic retinopathy
糖尿病视网膜病变内源性抗氧化系统的调节
- 批准号:
8584291 - 财政年份:2012
- 资助金额:
$ 37.5万 - 项目类别:
Regulation of endogenous antioxidant systems in diabetic retinopathy
糖尿病视网膜病变内源性抗氧化系统的调节
- 批准号:
8439994 - 财政年份:2012
- 资助金额:
$ 37.5万 - 项目类别:
Regulation of endogenous antioxidant systems in diabetic retinopathy
糖尿病视网膜病变内源性抗氧化系统的调节
- 批准号:
9186548 - 财政年份:2012
- 资助金额:
$ 37.5万 - 项目类别:
相似海外基金
Investigating the functions of histone acetylation in genome organization and leukemogenesis
研究组蛋白乙酰化在基因组组织和白血病发生中的功能
- 批准号:
EP/Y000331/1 - 财政年份:2023
- 资助金额:
$ 37.5万 - 项目类别:
Research Grant
Gene Modulation of Acetylation Modifiers to Reveal Regulatory Links to Human Cardiac Electromechanics
乙酰化修饰剂的基因调节揭示与人类心脏机电的调节联系
- 批准号:
10677295 - 财政年份:2023
- 资助金额:
$ 37.5万 - 项目类别:
Novel roles of PDK2 in heart failure: Regulation of mitochondrial nuclear crosstalk via metabolic regulation and histone acetylation
PDK2 在心力衰竭中的新作用:通过代谢调节和组蛋白乙酰化调节线粒体核串扰
- 批准号:
10635599 - 财政年份:2023
- 资助金额:
$ 37.5万 - 项目类别:
Regulation of hepatic lysine N-acetylation by cysteine proximity due to alcohol toxicity
酒精毒性导致的半胱氨酸接近对肝脏赖氨酸 N-乙酰化的调节
- 批准号:
10752320 - 财政年份:2023
- 资助金额:
$ 37.5万 - 项目类别:
Histone Acetylation Regulates Microglial Innate Immune Memory
组蛋白乙酰化调节小胶质细胞先天免疫记忆
- 批准号:
478927 - 财政年份:2023
- 资助金额:
$ 37.5万 - 项目类别:
Operating Grants
Dysregulation of Histone Acetylation in Parkinson's Disease
帕金森病中组蛋白乙酰化的失调
- 批准号:
10855703 - 财政年份:2023
- 资助金额:
$ 37.5万 - 项目类别:
Obesity-related hypertension: the contribution of PPAR gamma acetylation and asprosin
肥胖相关高血压:PPAR γ 乙酰化和白脂素的贡献
- 批准号:
10654210 - 财政年份:2023
- 资助金额:
$ 37.5万 - 项目类别:
The role N-terminal acetylation in dilated cardiomyopathy and associated arrhythmia
N-末端乙酰化在扩张型心肌病和相关心律失常中的作用
- 批准号:
10733915 - 财政年份:2023
- 资助金额:
$ 37.5万 - 项目类别:
In vivo tracing of hepatic ethanol metabolism to histone acetylation: role of ACSS2 in alcohol-induced liver injury
肝脏乙醇代谢与组蛋白乙酰化的体内追踪:ACSS2 在酒精性肝损伤中的作用
- 批准号:
10667952 - 财政年份:2023
- 资助金额:
$ 37.5万 - 项目类别:
The function of TWIST1 acetylation in cell fate and tissue development
TWIST1 乙酰化在细胞命运和组织发育中的作用
- 批准号:
10726986 - 财政年份:2023
- 资助金额:
$ 37.5万 - 项目类别: